Skip to main content
Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D
Accelerating Early-Stage Drug Discovery: How Novalix Integrates CDD Vault and StarDrop for Smarter R&D
The collaboration will also serve as a foundation for broader enterprise adoption, hgelping to define how AI-enabled capabilities are deployed
Simulations Plus announces strategic collaboration to advance AI modelling in pharma
An example of the visual output provided by the new QuanSA PyMOL plugin
Optibrium introduces graphical interface for QuanSA to enhance ligand-based affinity predictions
Ai drug discovery
Earendil Labs secures $787 million to scale AI-driven biologics discovery and development
UK consortium to help accelerate the adoption of low carbon medicines manufacturing
UK consortium to help accelerate adoption of low carbon medicinal manufacturing
Prof Hazel Screen, Professor of Biomedical Engineering, Queen Mary University of London and Dr Dave Powell, President of Drug Discovery, Relation Therapeutics
ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026
collaboration to add features to ELN
CCDC announces AI technology partnership with Sapio Sciences
AI-infused drug discovery
SandboxAQ launches open-source AI model for pharma R&D
Conceptual diagram showing the flow of analytical data from laboratory instruments through automated processing pipelines to unified study records, with scientists controlling workflow configuration through an intuitive interface
The key to effective chemical R&D workflow automation: putting in-house experts in control
AI-assissted molecular mnodelling
Optibrium aims to solve real-world efficiency and productivity challenges using AI

Media Partners